Is now the time for an intervention to prevent autoimmune type 1 diabetes?

Pediatric Diabetes

Volumn 2, Issue 1, 2001, Pages 12-16

  Lipton, Rebecca B ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Children and adolescents; Clinical trials; Intervention; Prevention; Screening; Type 1 diabetes mellitus

Indexed keywords

ANTIOXIDANT; AUTOANTIBODY; AZATHIOPRINE; CYCLOSPORIN A; GLUCOSE; HLA DQ ANTIGEN; HLA DR ANTIGEN; INSULIN; NICOTINAMIDE; TACROLIMUS;

ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNE DISEASE; CELL FUNCTION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; GENETIC MARKER; HLA TYPING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; INTRAVENOUS GLUCOSE TOLERANCE TEST; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PATIENT SELECTION; PRIORITY JOURNAL; RAT; RISK; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SIDE EFFECT;

EID: 0035030844     PISSN: 1399543X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-543x.2001.020103.x     Document Type: Article

References (23)

1. From pathomechanisms to prediction, prevention and improved care insulin-dependent diabetes in children
2. The Deutsche Nicotinamide Intervention Study: An attempt to prevent type 1 diabetes. DENIS Group
3. A population-based strategy to prevent insulin-dependent diabetes using nicotinamide
4. Immunologic 'vaccination' for the prevention of autoimmune diabetes (type 1a)
5. Prevention of type 1 diabetes: Is now the time?
6. Evaluation of preventive services
7. Screening for neuroblastoma in infants: Investigate or implement?
8. The pathogenesis of insulin-dependent diabetes mellitus
9. Prediction of type 1 diabetes mellitus in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA 512/IA-2 autoantibodies
10. Islet cell antibodies predict insulin-dependent diabetes in US school age children as powerfully as in unaffected relatives
11. Worldwide differences in the incidence of type I diabetes are associated with amino acid variation at position 57 of the HLA-DQ beta chain
12. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus
13. The Type 1 Diabetes Prediction and Prevention Project in Finland: 4.5 years of population-based genetic screening, follow-up and prevention (Abstract)
14. Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients
15. Intranasal insulin trial in preclinical type 1 diabetes (Abstract)
16. Cyclosporine therapy for the prevention and cure of insulin-dependent diabetes mellitus: An epidemiologic perspective of benefits and risks
17. Induction of autoimmune diabetes by oral administration of autoantigen
18. The DPT-1 intravenous insulin infusion suppresses endogenous insulin secretion but causes post-prandial glucose intolerance
19. Prospective Assessment in Newborns for Diabetes Autoimmunity (PANDA): A newborn diabetes screening program in the general population of Florida
20. Newborn screening for HLA markers associated with IDDM. Diabetes Autoimmunity Study Young (DAISY)